FDA Disclaimer: The content and products mentioned on this website have not been evaluated by the U.S. Food and Drug Administration (FDA). These products are not intended to diagnose, treat, cure, or prevent any disease. All products are sold exclusively for research, laboratory, or analytical purposes and are not intended for human consumption. The information provided is strictly for informational purposes only. Free shipping on orders over $300 and a 100% customer satisfaction money-back guarantee. All products are sold for research, laboratory, or analytical purposes only, and are not for human consumption. PRODUCTS ARE NOT FOR RESALE.
FDA Disclaimer: The content and products mentioned on this website have not been evaluated by the U.S. Food and Drug Administration (FDA). These products are not intended to diagnose, treat, cure, or prevent any disease. All products are sold exclusively for research, laboratory, or analytical purposes and are not intended for human consumption. The information provided is strictly for informational purposes only. All products are sold for research, laboratory, or analytical purposes only, and are not for human consumption. PRODUCTS ARE NOT FOR RESALE.

Cartalax (AED) 15mg

$50.00

Cartalax is a synthetic tripeptide bioregulator with the sequence Ala-Glu-Asp. It is provided as a lyophilized powder in a 3ml vial for research use only.

Cartalax is a synthetic tripeptide bioregulator with the sequence Ala-Glu-Asp. It is provided as a lyophilized powder in a 3ml vial for research use only.Sequence: Ala-Glu-Asp (AED)Molecular Formula: C₁₂H₁₉N₃O₈Molecular Weight: 333.29 Da (free acid)Synonyms: AED peptide, T-31, Alanyl-glutamyl-aspartic acidPurity: ≥98% (HPLC)Form: Lyophilized white powderQuantity: 20 mg per vialSolubility: Soluble in sterile water or bacteriostatic waterIntended Use:This product is intended strictly for in vitro and in vivo laboratory research purposes. Cartalax is commonly studied in regenerative medicine, gerontology, and connective tissue research for its potential effects on chondrocytes, fibroblasts, and extracellular matrix regulation in cartilage and joint models.Key Research Areas:• Cartilage and connective tissue regeneration• Modulation of gene expression in chondrocytes and fibroblasts• Support of extracellular matrix homeostasis• Age-related changes in joint and connective tissue

RUO Compliant Product Description for Cartalax 15mg
For Research Use Only. Not for human consumption, diagnostic, or therapeutic use. This product is not approved by the FDA or any other regulatory agency for use in humans or animals. Handle according to standard laboratory safety protocols for peptides. Researchers must ensure compliance with all local, state, and federal regulations regarding the use of research chemicals.

Reviews

There are no reviews yet.

Be the first to review “Cartalax (AED) 15mg”

Your email address will not be published. Required fields are marked *

five − four =

No FAQs added for this product yet.

Scroll to Top